Ep 520: How Pilothouse Tests 30+ Creatives Weekly on Meta: A Practical Guide | AKNF
DTC Podcast · with Taylor Cain and Jacob · June 27, 2025 · 24 min
Summary
This episode provides an in-depth look at how high-volume DTC brands can efficiently test and scale ad creatives on Meta. Pilothouse shares their hybrid strategy, using ABO for creative discovery and Advantage Plus/CBO for scaling, while keeping testing spend to a lean 5-10% of the total budget. Learn how to navigate Meta's algorithms, understand "net-new creative," and strategize for seasonal peaks like Q4.
Key takeaways
Implement a hybrid Meta ad testing strategy: use ABO for high-velocity creative discovery and Advantage Plus/CBO for scaling proven winners to optimize budget and performance.
Allocate only 5-10% of the total ad budget to creative testing to manage risk predictably while still enabling rapid experimentation.
Understand how Meta defines "net-new creative" and optimize visuals, text, and video intros to positively influence ad delivery and performance.
Develop a seasonality playbook to capitalize on lower CPMs (e.g., pre-summer for Q4 stocking) and strategically plan ad spend for peak seasons like Q4.
Balance Meta's AI-driven ad delivery systems (Andromeda, GEM, Lattice) with strategic human oversight to maintain control and optimize media buying efforts.
For health and wellness brands facing Meta tracking limitations, explore channel diversification options like AppLovin to mitigate data permission challenges.
Subscribe to DTC Newsletter - https://dtcnews.link/signupIn this episode of the DTC Podcast, Eric Dyck hosts Taylor Cain and Jacob from Pilothouse Meta Brain Trust to unpack how high-volume DTC brands test creative at scale on Meta. Learn their hybrid approach using ABO for insight discovery and Advantage Plus/CBO for scaling winners—while keeping testing spend lean at 5–10% of total budget.Key Moments & Takeaways:30+ ads/week testing: how they structure ABO for high-velocity creative discoveryBudget allocation: keep risk predictable by dedicating a small portion to testsMeta signals: what defines ‘net-new creative’ and how visuals/text/video intros affect deliveryAI vs. human oversight: balancing Meta’s algorithm with strategic media buyingHealth & wellness challenges: dealing with regressions in data permissionsChannel diversification: why brands pivot to AppLovin amid Meta data limitationsSeasonality playbook: capitalizing on lower CPMs pre-summer and prepping for prime Q4Did you know that 98% of your website visitors are anonymous? Instant powers next-level retention by identifying who they are and converting them into loyal shoppers. Sign up for a quick demo today to get 50% off and unlock a guaranteed 4x+ ROI: instant.one/dtcTimestamps00:00 – Why July is the best time to stock the pond for Q402:05 – Creative testing structures: ABO vs. ASC vs. CBO06:50 – Meta’s evolving definition of “net new creative”11:55 – How Meta’s AI systems (Andromeda, GEM, Lattice) influence delivery17:35 – Health and wellness brands and Meta’s tracking limitations22:00 – A
What does this episode say about paid acquisition?
Implement a hybrid Meta ad testing strategy: use ABO for high-velocity creative discovery and Advantage Plus/CBO for scaling proven winners to optimize budget and performance.
What does this episode say about dtc strategy?
Allocate only 5-10% of the total ad budget to creative testing to manage risk predictably while still enabling rapid experimentation.
What does this episode say about ai & automation?
Understand how Meta defines "net-new creative" and optimize visuals, text, and video intros to positively influence ad delivery and performance.
What does this episode say about paid acquisition?
Develop a seasonality playbook to capitalize on lower CPMs (e.g., pre-summer for Q4 stocking) and strategically plan ad spend for peak seasons like Q4.
What does this episode say about paid acquisition?
Balance Meta's AI-driven ad delivery systems (Andromeda, GEM, Lattice) with strategic human oversight to maintain control and optimize media buying efforts.
